All Stories

  1. Decline in FEV1 and hospitalized exacerbations in individuals with severe alpha-1 antitrypsin deficiency

    Article • International Journal of Chronic Obstructive Pulmonary Disease, May 2019, Dove Medical Press

    Eeva Piitulainen, Dr Hanan A Tanash, Adriana-Maria Hiller

  2. Survival in the Swedish cohort with alpha-1-antitrypsin deficiency, up to the age of 43–45 years

    Article • International Journal of Chronic Obstructive Pulmonary Disease, February 2019, Dove Medical Press

    Dr Hanan A Tanash, Eeva Piitulainen

  3. Lung function and CT lung densitometry in 37- to 39-year-old individuals with alpha-1-antitrypsin deficiency

    Article • International Journal of Chronic Obstructive Pulmonary Disease, November 2018, Dove Medical Press

    Eeva Piitulainen, Sandra Diaz Ruiz, Dr Hanan A Tanash

  4. Lung transplantation and survival outcomes in patients with oxygen-dependent COPD with regard to their alpha-1 antitrypsin deficiency status

    Article • International Journal of Chronic Obstructive Pulmonary Disease, November 2017, Dove Medical Press

    Dr Hanan A Tanash

  5. Risk of cancer after lung transplantation for COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, October 2017, Dove Medical Press

    Dr Hanan A Tanash

  6. Survival in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison to a general population with known smoking habits

    Article • European Respiratory Journal, September 2017, European Respiratory Society (ERS)

    Dr Hanan A Tanash

  7. Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years

    Article • International Journal of Chronic Obstructive Pulmonary Disease, February 2017, Dove Medical Press

    Dr Hanan A Tanash, Eeva Piitulainen

  8. Burn injury during long-term oxygen therapy in Denmark and Sweden: the potential role of smoking

    Article • International Journal of Chronic Obstructive Pulmonary Disease, January 2017, Dove Medical Press

    Dr Hanan A Tanash, Dr Fredrik Huss, Dr Thomas J Ringbaek

  9. Cause-specific mortality in individuals with severe alpha 1-antitrypsin deficiency in comparison with the general population in Sweden

    Article • International Journal of Chronic Obstructive Pulmonary Disease, July 2016, Dove Medical Press

    Dr Hanan A Tanash, Eeva Piitulainen

  10. The risk of burn injury during long-term oxygen therapy: a 17-year longitudinal national study in Sweden

    Article • International Journal of Chronic Obstructive Pulmonary Disease, November 2015, Dove Medical Press

    Dr Fredrik Huss, Dr Hanan A Tanash